Affimed
AFMD
$0.18
Share price
0.00%
Change (1 day)
-97.31%
Change (1 year)
Categories
Affimed (AFMD) Fails to deliver data
Key failure to deliver metrics for Affimed :
- Last SEC data release: 2025-05-14
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $0 M
- Last year FTD volume: $0 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Affimed (AFMD) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Affimed (AFMD) - since 2024
Volume in USD (price x number of shares), data since 2024Affimed (AFMD) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | $0.06 M | -97.44% |
| 2024 | $2.43 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Acorda Therapeutics
ACOR | N/A | $0.01 M | 🇺🇸 USA |
 Agenus
AGEN | $0.93 M | $4.81 M | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | N/A | $4.65 M | 🇺🇸 USA |
 Repligen
RGEN | $7.41 M | $24.54 M | 🇺🇸 USA |